Molecular mechanisms of ethanol-associated oro-esophageal squamous cell carcinoma

Cancer Letters

Volumn 361, Issue 2, 2015, Pages 164-173

  Liu, Yao ^a,b   Chen, Hao ^b   Sun, Zheng ^a   Chen, Xiaoxin ^b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b NORTH CAROLINA CENTRAL UNIVERSITY   (United States)

Author keywords

Ethanol; Molecular mechanisms; Oro esophageal squamous cell carcinoma

Indexed keywords

ALCOHOL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IRON; NOTCH RECEPTOR; REACTIVE OXYGEN METABOLITE; RETINOID; SONIC HEDGEHOG PROTEIN; TOLL LIKE RECEPTOR 4; TRANSFORMING GROWTH FACTOR BETA; WNT PROTEIN; ZINC;

ALCOHOL ABUSE; ALCOHOL CONSUMPTION; ALCOHOL METABOLISM; ALCOHOLISM; CELL MEMBRANE FLUIDITY; CHEMICAL CARCINOGENESIS; CHRONIC INFLAMMATION; ESOPHAGUS CANCER; FATTY ACID METABOLISM; HUMAN; IRON METABOLISM; IRON OVERLOAD; LIVER METABOLISM; MOUTH CANCER; NONHUMAN; OROESOPHAGEAL SQUAMOUS CELL CARCINOMA; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; SHORT SURVEY; SIGNAL TRANSDUCTION; TUMOR PROMOTION; VITAMIN METABOLISM; ZINC DEFICIENCY; ZINC METABOLISM; ADVERSE EFFECTS; CARCINOMA, SQUAMOUS CELL; DRINKING BEHAVIOR; ESOPHAGEAL NEOPLASMS; METABOLISM;

ALCOHOL DRINKING; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; ETHANOL; HUMANS; SIGNAL TRANSDUCTION;

EID: 84926125889     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2015.03.006     Document Type: Review

References (205)

1. Siegel R., Ma J., Zou Z., Jemal A. Cancer statistics, 2014. CA Cancer J. Clin 2014, 64:9-29.
2. Mackenzie J., Ah-See K., Thakker N., Sloan P., Maran A.G., Birch J., et al. Increasing incidence of oral cancer amongst young persons: what is the aetiology?. Oral Oncol 2000, 36:387-389.
3. Davis S., Severson R.K. Increasing incidence of cancer of the tongue in the United States among young adults. Lancet 1987, 2:910-911.
4. Stelow E.B., Mills S.E. Squamous cell carcinoma variants of the upper aerodigestive tract. Am. J. Clin. Pathol 2005, 124(Suppl.):S96-S109.
5. Franceschi S., Levi F., Vecchia C. Decline in 5-year survival rates for cancer of head and neck. Lancet 1992, 340:47.
6. Chuang S.C., Scelo G., Tonita J.M., Tamaro S., Jonasson J.G., Kliewer E.V., et al. Risk of second primary cancer among patients with head and neck cancers: a pooled analysis of 13 cancer registries. Int. J. Cancer 2008, 123:2390-2396.
7. Chuang S.C., Hashibe M., Scelo G., Brewster D.H., Pukkala E., Friis S., et al. Risk of second primary cancer among esophageal cancer patients: a pooled analysis of 13 cancer registries. Cancer Epidemiol. Biomarkers Prev 2008, 17:1543-1549.
8. Bagnardi V., Blangiardo M., La Vecchia C., Corrao G. A meta-analysis of alcohol drinking and cancer risk. Br. J. Cancer 2001, 85:1700-1705.
9. Li Y., Mao Y., Zhang Y., Cai S., Chen G., Ding Y., et al. Alcohol drinking and upper aerodigestive tract cancer mortality: a systematic review and meta-analysis. Oral Oncol 2014, 50:269-275.
10. Marron M., Boffetta P., Moller H., Ahrens W., Pohlabeln H., Benhamou S., et al. Risk of upper aerodigestive tract cancer and type of alcoholic beverage: a European multicenter case-control study. Eur. J. Epidemiol 2012, 27:499-517.
11. Morse D.E., Psoter W.J., Cleveland D., Cohen D., Mohit-Tabatabai M., Kosis D.L., et al. Smoking and drinking in relation to oral cancer and oral epithelial dysplasia. Cancer Causes Control 2007, 18:919-929.
12. Tanaka F., Yamamoto K., Suzuki S., Inoue H., Tsurumaru M., Kajiyama Y., et al. Strong interaction between the effects of alcohol consumption and smoking on oesophageal squamous cell carcinoma among individuals with ADH1B and/or ALDH2 risk alleles. Gut 2010, 59:1457-1464.
13. Wu C., Kraft P., Zhai K., Chang J., Wang Z., Li Y., et al. Genome-wide association analyses of esophageal squamous cell carcinoma in Chinese identify multiple susceptibility loci and gene-environment interactions. Nat. Genet 2012, 44:1090-1097.
14. Oze I., Matsuo K., Suzuki T., Kawase T., Watanabe M., Hiraki A., et al. Impact of multiple alcohol dehydrogenase gene polymorphisms on risk of upper aerodigestive tract cancers in a Japanese population. Cancer Epidemiol. Biomarkers Prev 2009, 18:3097-3102.
15. Yokoyama A., Watanabe H., Fukuda H., Haneda T., Kato H., Yokoyama T., et al. Multiple cancers associated with esophageal and oropharyngolaryngeal squamous cell carcinoma and the aldehyde dehydrogenase-2 genotype in male Japanese drinkers. Cancer Epidemiol. Biomarkers Prev 2002, 11:895-900.
16. Yokoyama A., Omori T., Yokoyama T., Sato Y., Mizukami T., Matsushita S., et al. Risk of squamous cell carcinoma of the upper aerodigestive tract in cancer-free alcoholic Japanese men: an endoscopic follow-up study. Cancer Epidemiol. Biomarkers Prev 2006, 15:2209-2215.
17. Yokoyama A., Omori T. Genetic polymorphisms of alcohol and aldehyde dehydrogenases and risk for esophageal and head and neck cancers. Jpn. J. Clin. Oncol 2003, 33:111-121.
18. Matsuo K., Hamajima N., Shinoda M., Hatooka S., Inoue M., Takezaki T., et al. Gene-environment interaction between an aldehyde dehydrogenase-2 (ALDH2) polymorphism and alcohol consumption for the risk of esophageal cancer. Carcinogenesis 2001, 22:913-916.
19. Hashibe M., Boffetta P., Zaridze D., Shangina O., Szeszenia-Dabrowska N., Mates D., et al. Evidence for an important role of alcohol- and aldehyde-metabolizing genes in cancers of the upper aerodigestive tract. Cancer Epidemiol. Biomarkers Prev 2006, 15:696-703.
20. Bouchardy C., Hirvonen A., Coutelle C., Ward P.J., Dayer P., Benhamou S. Role of alcohol dehydrogenase 3 and cytochrome P-4502E1 genotypes in susceptibility to cancers of the upper aerodigestive tract. Int. J. Cancer 2000, 87:734-740.
21. Harty L.C., Caporaso N.E., Hayes R.B., Winn D.M., Bravo-Otero E., Blot W.J., et al. Alcohol dehydrogenase 3 genotype and risk of oral cavity and pharyngeal cancers. J. Natl Cancer Inst 1997, 89:1698-1705.
22. Pelucchi C., Gallus S., Garavello W., Bosetti C., La Vecchia C. Cancer risk associated with alcohol and tobacco use: focus on upper aero-digestive tract and liver. Alcohol. Res. Health 2006, 29:193-198.
23. Anantharaman D., Marron M., Lagiou P., Samoli E., Ahrens W., Pohlabeln H., et al. Population attributable risk of tobacco and alcohol for upper aerodigestive tract cancer. Oral Oncol 2011, 47:725-731.
24. Bell-Parikh L.C., Guengerich F.P. Kinetics of cytochrome P450 2E1-catalyzed oxidation of ethanol to acetic acid via acetaldehyde. J. Biol. Chem 1999, 274:23833-23840.
25. Kunitoh S., Imaoka S., Hiroi T., Yabusaki Y., Monna T., Funae Y. Acetaldehyde as well as ethanol is metabolized by human CYP2E1. J. Pharmacol. Exp. Ther 1997, 280:527-532.
26. Seitz H.K., Stickel F. Molecular mechanisms of alcohol-mediated carcinogenesis. Nat. Rev. Cancer 2007, 7:599-612.
27. Homann N., Jousimies-Somer H., Jokelainen K., Heine R., Salaspuro M. High acetaldehyde levels in saliva after ethanol consumption: methodological aspects and pathogenetic implications. Carcinogenesis 1997, 18:1739-1743.
28. Homann N., Tillonen J., Meurman J.H., Rintamaki H., Lindqvist C., Rautio M., et al. Increased salivary acetaldehyde levels in heavy drinkers and smokers: a microbiological approach to oral cavity cancer. Carcinogenesis 2000, 21:663-668.
29. Salaspuro M.P. Acetaldehyde, microbes, and cancer of the digestive tract. Crit. Rev. Clin. Lab. Sci 2003, 40:183-208.
30. Poschl G., Seitz H.K. Alcohol and cancer. Alcohol Alcohol 2004, 39:155-165.
31. Du X., Squier C.A., Kremer M.J., Wertz P.W. Penetration of N-nitrosonornicotine (NNN) across oral mucosa in the presence of ethanol and nicotine. J. Oral Pathol. Med 2000, 29:80-85.
32. Kornfehl J., Temmel A., Formanek M., Knerer B. Effects of ethanol treatment of proliferation and differentiation in a head and neck squamous cell carcinoma cell line. Alcohol. Clin. Exp. Res 1999, 23:1102-1107.
33. McKillop I.H., Schrum L.W. Alcohol and liver cancer. Alcohol 2005, 35:195-203.
34. Purohit V., Rapaka R., Kwon O.S., Song B.J. Roles of alcohol and tobacco exposure in the development of hepatocellular carcinoma. Life Sci 2013, 92:3-9.
35. Guo Y., Wang X., Zhang X., Sun Z., Chen X. Ethanol promotes chemically induced oral cancer in mice through activation of the 5-lipoxygenase pathway of arachidonic acid metabolism. Cancer Prev. Res. (Phila.) 2011, 4:1863-1872.
36. Wang X.D. Alcohol, vitamin A, and cancer. Alcohol 2005, 35:251-258.
37. Shiraishi-Yokoyama H., Yokoyama H., Matsumoto M., Imaeda H., Hibi T. Acetaldehyde inhibits the formation of retinoic acid from retinal in the rat esophagus. Scand. J. Gastroenterol 2006, 41:80-86.
38. Liu L., Tang X.H., Scognamiglio T., Gudas L.J. Oral carcinogenesis induced by 4-nitroquinoline 1-oxide in lecithin:retinol acyltransferase gene knockout mice. J. Nutr. Biochem 2010, 21:975-982.
39. Toma S., Bonelli L., Sartoris A., Mira E., Antonelli A., Beatrice F., et al. 13-cis retinoic acid in head and neck cancer chemoprevention: results of a randomized trial from the Italian Head and Neck Chemoprevention Study Group. Oncol. Rep 2004, 11:1297-1305.
40. Tang X.H., Osei-Sarfo K., Urvalek A.M., Zhang T., Scognamiglio T., Gudas L.J. Combination of bexarotene and the retinoid CD1530 reduces murine oral-cavity carcinogenesis induced by the carcinogen 4-nitroquinoline 1-oxide. Proc. Natl. Acad. Sci. U.S.A. 2014, 111:8907-8912.
41. Joshi P.C., Mehta A., Jabber W.S., Fan X., Guidot D.M. Zinc deficiency mediates alcohol-induced alveolar epithelial and macrophage dysfunction in rats. Am. J. Respir. Cell Mol. Biol 2009, 41:207-216.
42. Curry-McCoy T.V., Guidot D.M., Joshi P.C. Chronic alcohol ingestion in rats decreases Kruppel-like factor 4 expression and intracellular zinc in the lung. Alcohol. Clin. Exp. Res 2013, 37:361-371.
43. Zhou Z., Wang L., Song Z., Saari J.T., McClain C.J., Kang Y.J. Zinc supplementation prevents alcoholic liver injury in mice through attenuation of oxidative stress. Am. J. Pathol 2005, 166:1681-1690.
44. Fong L.Y., Zhang L., Jiang Y., Farber J.L. Dietary zinc modulation of COX-2 expression and lingual and esophageal carcinogenesis in rats. J. Natl Cancer Inst 2005, 97:40-50.
45. Mathur A., Wallenius K., Abdulla M. Influence of zinc on onset and progression of oral carcinogenesis in rats. Acta Odontol. Scand 1979, 37:277-284.
46. Liu C.G., Zhang L., Jiang Y., Chatterjee D., Croce C.M., Huebner K., et al. Modulation of gene expression in precancerous rat esophagus by dietary zinc deficit and replenishment. Cancer Res 2005, 65:7790-7799.
47. Taccioli C., Wan S.G., Liu C.G., Alder H., Volinia S., Farber J.L., et al. Zinc replenishment reverses overexpression of the proinflammatory mediator S100A8 and esophageal preneoplasia in the rat. Gastroenterology 2009, 136:953-966.
48. Taccioli C., Chen H., Jiang Y., Liu X.P., Huang K., Smalley K.J., et al. Dietary zinc deficiency fuels esophageal cancer development by inducing a distinct inflammatory signature. Oncogene 2012, 31:4550-4558.
49. Sun J., Liu J., Pan X., Quimby D., Zanesi N., Druck T., et al. Effect of zinc supplementation on N-nitrosomethylbenzylamine-induced forestomach tumor development and progression in tumor suppressor-deficient mouse strains. Carcinogenesis 2011, 32:351-358.
50. Fong L.Y., Jiang Y., Rawahneh M.L., Smalley K.J., Croce C.M., Farber J.L., et al. Zinc supplementation suppresses 4-nitroquinoline 1-oxide-induced rat oral carcinogenesis. Carcinogenesis 2011, 32:554-560.
51. Harrison-Findik D.D. Role of alcohol in the regulation of iron metabolism. World J. Gastroenterol 2007, 13:4925-4930.
52. Do T.H., Gaboriau F., Cannie I., Batusanski F., Ropert M., Moirand R., et al. Iron-mediated effect of alcohol on hepatocyte differentiation in HepaRG cells. Chem. Biol. Interact 2013, 206:117-125.
53. Chen X., Yang C.S. Esophageal adenocarcinoma: a review and perspectives on the mechanism of carcinogenesis and chemoprevention. Carcinogenesis 2001, 22:1119-1129.
54. Deugnier Y. Iron and liver cancer. Alcohol 2003, 30:145-150.
55. Schieber M., Chandel N.S. ROS function in redox signaling and oxidative stress. Curr. Biol 2014, 24:R453-R462.
56. Nogueira V., Hay N. Molecular pathways: reactive oxygen species homeostasis in cancer cells and implications for cancer therapy. Clin. Cancer Res 2013, 19:4309-4314.
57. Lu S.C., Mato J.M. Role of methionine adenosyltransferase and S-adenosylmethionine in alcohol-associated liver cancer. Alcohol 2005, 35:227-234.
58. Mason J.B., Choi S.W. Effects of alcohol on folate metabolism: implications for carcinogenesis. Alcohol 2005, 35:235-241.
59. Zapisek W.F., Cronin G.M., Lyn-Cook B.D., Poirier L.A. The onset of oncogene hypomethylation in the livers of rats fed methyl-deficient, amino acid-defined diets. Carcinogenesis 1992, 13:1869-1872.
60. Pogribny I.P., Ross S.A., Wise C., Pogribna M., Jones E.A., Tryndyak V.P., et al. Irreversible global DNA hypomethylation as a key step in hepatocarcinogenesis induced by dietary methyl deficiency. Mutat. Res 2006, 593:80-87.
61. Gasche J.A., Goel A. Epigenetic mechanisms in oral carcinogenesis. Future Oncol 2012, 8:1407-1425.
62. Kuo I.Y., Chang J.M., Jiang S.S., Chen C.H., Chang I.S., Sheu B.S., et al. Prognostic CpG methylation biomarkers identified by methylation array in esophageal squamous cell carcinoma patients. Int. J. Med. Sci 2014, 11:779-787.
63. Jithesh P.V., Risk J.M., Schache A.G., Dhanda J., Lane B., Liloglou T., et al. The epigenetic landscape of oral squamous cell carcinoma. Br. J. Cancer 2013, 108:370-379.
64. Pan Q.F., Li W.T., Dong H.C., Chen Y.Z., Yin L., Liu W., et al. PTEN hypermethylation profiles of Chinese Kazakh patients with esophageal squamous cell carcinoma. Dis. Esophagus 2014, 27:396-402.
65. Chan S.L., Cui Y., van Hasselt A., Li H., Srivastava G., Jin H., et al. The tumor suppressor Wnt inhibitory factor 1 is frequently methylated in nasopharyngeal and esophageal carcinomas. Lab. Invest 2007, 87:644-650.
66. Biggar K.K., Li S.S. Non-histone protein methylation as a regulator of cellular signalling and function. Nat. Rev. Mol. Cell Biol 2015, 16:5-17.
67. Ogden G.R. Alcohol and oral cancer. Alcohol 2005, 35:169-173.
68. Dong Y.J., Peng T.K., Yin S.J. Expression and activities of class IV alcohol dehydrogenase and class III aldehyde dehydrogenase in human mouth. Alcohol 1996, 13:257-262.
69. Shimizu M., Lasker J.M., Tsutsumi M., Lieber C.S. Immunohistochemical localization of ethanol-inducible P450IIE1 in the rat alimentary tract. Gastroenterology 1990, 99:1044-1053.
70. Lechevrel M., Wild C.P. Absence of a differential induction of cytochrome P450 2E1 by different alcoholic beverages in rats: implications for the aetiology of human oesophageal cancer. Arch. Toxicol 1997, 71:690-695.
71. Yang S.P., Medling T., Raner G.M. Cytochrome P450 expression and activities in rat, rabbit and bovine tongue. Comp. Biochem. Physiol. C Toxicol. Pharmacol 2003, 136:297-308.
72. Albano E. Alcohol, oxidative stress and free radical damage. Proc. Nutr. Soc 2006, 65:278-290.
73. Eskelson C.D., Odeleye O.E., Watson R.R., Earnest D.L., Mufti S.I. Modulation of cancer growth by vitamin E and alcohol. Alcohol Alcohol 1993, 28:117-125.
74. Yang S.F., Chang C.W., Wei R.J., Shiue Y.L., Wang S.N., Yeh Y.T. Involvement of DNA damage response pathways in hepatocellular carcinoma. Biomed Res. Int 2014, 2014:153867.
75. Brooks P.J., Zakhari S. Acetaldehyde and the genome: beyond nuclear DNA adducts and carcinogenesis. Environ. Mol. Mutagen 2014, 55:77-91.
76. Yu H.S., Oyama T., Matsuda T., Isse T., Yamaguchi T., Tanaka M., et al. The effect of ethanol on the formation of N2-ethylidene-dG adducts in mice: implications for alcohol-related carcinogenicity of the oral cavity and esophagus. Biomarkers 2012, 17:269-274.
77. Balbo S., Meng L., Bliss R.L., Jensen J.A., Hatsukami D.K., Hecht S.S. Kinetics of DNA adduct formation in the oral cavity after drinking alcohol. Cancer Epidemiol. Biomarkers Prev 2012, 21:601-608.
78. Yukawa Y., Muto M., Hori K., Nagayoshi H., Yokoyama A., Chiba T., et al. Combination of ADH1B*2/ALDH2*2 polymorphisms alters acetaldehyde-derived DNA damage in the blood of Japanese alcoholics. Cancer Sci 2012, 103:1651-1655.
79. Choudhari S.K., Chaudhary M., Gadbail A.R., Sharma A., Tekade S. Oxidative and antioxidative mechanisms in oral cancer and precancer: a review. Oral Oncol 2013, 50:10-18.
80. Warnakulasuriya S., Parkkila S., Nagao T., Preedy V.R., Pasanen M., Koivisto H., et al. Demonstration of ethanol-induced protein adducts in oral leukoplakia (pre-cancer) and cancer. J. Oral Pathol. Med 2008, 37:157-165.
81. Roychowdhury S., McMullen M.R., Pritchard M.T., Li W., Salomon R.G., Nagy L.E. Formation of gamma-ketoaldehyde-protein adducts during ethanol-induced liver injury in mice. Free Radic. Biol. Med 2009, 47:1526-1538.
82. Niemela O., Parkkila S., Worrall S., Emery P.W., Preedy V.R. Generation of aldehyde-derived protein modifications in ethanol-exposed heart. Alcohol. Clin. Exp. Res 2003, 27:1987-1992.
83. Aleynik S.I., Leo M.A., Aleynik M.K., Lieber C.S. Increased circulating products of lipid peroxidation in patients with alcoholic liver disease. Alcohol. Clin. Exp. Res 1998, 22:192-196.
84. Shepard B.D., Tuma P.L. Alcohol-induced protein hyperacetylation: mechanisms and consequences. World J. Gastroenterol 2009, 15:1219-1230.
85. Wu K.C., Liu J., Klaassen C.D. Role of Nrf2 in preventing ethanol-induced oxidative stress and lipid accumulation. Toxicol. Appl. Pharmacol 2012, 262:321-329.
86. Buelna-Chontal M., Zazueta C. Redox activation of Nrf2 & NF-kappaB: a double end sword?. Cell. Signal 2013, 25:2548-2557.
87. Ganan-Gomez I., Wei Y., Yang H., Boyano-Adanez M.C., Garcia-Manero G. Oncogenic functions of the transcription factor Nrf2. Free Radic. Biol. Med 2013, 65:750-764.
88. Ohkoshi A., Suzuki T., Ono M., Kobayashi T., Yamamoto M. Roles of Keap1-Nrf2 system in upper aerodigestive tract carcinogenesis. Cancer Prev. Res. (Phila.) 2013, 6:149-159.
89. Jensen J.S., Fan X., Guidot D.M. Alcohol causes alveolar epithelial oxidative stress by inhibiting the nuclear factor (erythroid-derived 2)-like 2-antioxidant response element signaling pathway. Am. J. Respir. Cell Mol. Biol 2013, 48:511-517.
90. Ushida Y., Talalay P. Sulforaphane accelerates acetaldehyde metabolism by inducing aldehyde dehydrogenases: relevance to ethanol intolerance. Alcohol Alcohol 2013, 48:526-534.
91. Crabb D.W., Galli A., Fischer M., You M. Molecular mechanisms of alcoholic fatty liver: role of peroxisome proliferator-activated receptor alpha. Alcohol 2004, 34:35-38.
92. Sozio M., Crabb D.W. Alcohol and lipid metabolism. Am. J. Physiol. Endocrinol. Metab 2008, 295:E10-E16.
93. Fernando H., Bhopale K.K., Kondraganti S., Kaphalia B.S., Shakeel Ansari G.A. Lipidomic changes in rat liver after long-term exposure to ethanol. Toxicol. Appl. Pharmacol 2011, 255:127-137.
94. Lieber C.S. Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis. Alcohol 2004, 34:9-19.
95. Lewis J.A., Elkon I.M., McGee M.A., Higbee A.J., Gasch A.P. Exploiting natural variation in Saccharomyces cerevisiae to identify genes for increased ethanol resistance. Genetics 2010, 186:1197-1205.
96. Stanley D., Bandara A., Fraser S., Chambers P.J., Stanley G.A. The ethanol stress response and ethanol tolerance of Saccharomyces cerevisiae. J. Appl. Microbiol 2010, 109:13-24.
97. Blume J.J., Halbach A., Behrendt D., Paulsson M., Plomann M. EHD proteins are associated with tubular and vesicular compartments and interact with specific phospholipids. Exp. Cell Res 2007, 313:219-231.
98. Naslavsky N., Rahajeng J., Rapaport D., Horowitz M., Caplan S. EHD1 regulates cholesterol homeostasis and lipid droplet storage. Biochem. Biophys. Res. Commun 2007, 357:792-799.
99. Shimano H. Novel qualitative aspects of tissue fatty acids related to metabolic regulation: lessons from Elovl6 knockout. Prog. Lipid Res 2012, 51:267-271.
100. Matsuzaka T., Shimano H., Yahagi N., Kato T., Atsumi A., Yamamoto T., et al. Crucial role of a long-chain fatty acid elongase, Elovl6, in obesity-induced insulin resistance. Nat. Med 2007, 13:1193-1202.
101. Zadravec D., Brolinson A., Fisher R.M., Carneheim C., Csikasz R.I., Bertrand-Michel J., et al. Ablation of the very-long-chain fatty acid elongase ELOVL3 in mice leads to constrained lipid storage and resistance to diet-induced obesity. FASEB J. 2010, 24:4366-4377.
102. Kobayashi T., Fujimori K. Very long-chain-fatty acids enhance adipogenesis through coregulation of Elovl3 and PPARgamma in 3T3-L1 cells. Am. J. Physiol. Endocrinol. Metab 2012, 302:E1461-E1471.
103. Sonmez M., Ince H.Y., Yalcin O., Ajdzanovic V., Spasojevic I., Meiselman H.J., et al. The effect of alcohols on red blood cell mechanical properties and membrane fluidity depends on their molecular size. PLoS ONE 2013, 8:e76579.
104. Frischknecht A.L., Frink L.J. Alcohols reduce lateral membrane pressures: predictions from molecular theory. Biophys. J. 2006, 91:4081-4090.
105. Chiou J.S., Ma S.M., Kamaya H., Ueda I. Anesthesia cutoff phenomenon: interfacial hydrogen bonding. Science 1990, 248:583-585.
106. Bodhinathan K., Slesinger P.A. Molecular mechanism underlying ethanol activation of G-protein-gated inwardly rectifying potassium channels. Proc. Natl. Acad. Sci. U.S.A. 2013, 110:18309-18314.
107. Szabo G., Dolganiuc A., Dai Q., Pruett S.B. TLR4, ethanol, and lipid rafts: a new mechanism of ethanol action with implications for other receptor-mediated effects. J. Immunol 2007, 178:1243-1249.
108. Sun Z., Luo Q., Ye D., Chen W., Chen F. Role of toll-like receptor 4 on the immune escape of human oral squamous cell carcinoma and resistance of cisplatin-induced apoptosis. Mol. Cancer 2012, 11:33.
109. Ren W.H., Zhang L.M., Liu H.Q., Gao L., Chen C., Qiang C., et al. Protein overexpression of CIRP and TLR4 in oral squamous cell carcinoma: an immunohistochemical and clinical correlation analysis. Med. Oncol 2014, 31:120.
110. Sheyhidin I., Nabi G., Hasim A., Zhang R.P., Ainiwaer J., Ma H., et al. Overexpression of TLR3, TLR4, TLR7 and TLR9 in esophageal squamous cell carcinoma. World J. Gastroenterol 2011, 17:3745-3751.
111. Szczepanski M.J., Czystowska M., Szajnik M., Harasymczuk M., Boyiadzis M., Kruk-Zagajewska A., et al. Triggering of Toll-like receptor 4 expressed on human head and neck squamous cell carcinoma promotes tumor development and protects the tumor from immune attack. Cancer Res 2009, 69:3105-3113.
112. Mark R., Bermejo J.L., Bierhaus A., Plinkert P.K., Angel P., Hess J. The receptor for advanced glycation end products is dispensable in a mouse model of oral and esophageal carcinogenesis. Histol. Histopathol 2013, 28:1585-1594.
113. Vahle A.K., Kerem A., Ozturk E., Bankfalvi A., Lang S., Brandau S. Optimization of an orthotopic murine model of head and neck squamous cell carcinoma in fully immunocompetent mice - role of toll-like-receptor 4 expressed on host cells. Cancer Lett 2012, 317:199-206.
114. Paleja B., Anand A., Chaukar D., D'Cruz A., Chiplunkar S. Decreased functional response to Toll like receptor ligands in patients with oral cancer. Hum. Immunol 2013, 74:927-936.
115. Borggrefe T., Oswald F. The Notch signaling pathway: transcriptional regulation at Notch target genes. Cell. Mol. Life Sci 2009, 66:1631-1646.
116. Okuyama R., Tagami H., Aiba S. Notch signaling: its role in epidermal homeostasis and in the pathogenesis of skin diseases. J. Dermatol. Sci 2008, 49:187-194.
117. Ohashi S., Natsuizaka M., Yashiro-Ohtani Y., Kalman R.A., Nakagawa M., Wu L., et al. NOTCH1 and NOTCH3 coordinate esophageal squamous differentiation through a CSL-dependent transcriptional network. Gastroenterology 2010, 139:2113-2123.
118. Ohashi S., Natsuizaka M., Naganuma S., Kagawa S., Kimura S., Itoh H., et al. A NOTCH3-mediated squamous cell differentiation program limits expansion of EMT-competent cells that express the ZEB transcription factors. Cancer Res 2011, 71:6836-6847.
119. Blanpain C., Lowry W.E., Pasolli H.A., Fuchs E. Canonical notch signaling functions as a commitment switch in the epidermal lineage. Genes Dev 2006, 20:3022-3035.
120. Wang X., Pasolli H.A., Williams T., Fuchs E. AP-2 factors act in concert with Notch to orchestrate terminal differentiation in skin epidermis. J. Cell Biol 2008, 183:37-48.
121. Casey L.M., Lan Y., Cho E.S., Maltby K.M., Gridley T., Jiang R. Jag2-Notch1 signaling regulates oral epithelial differentiation and palate development. Dev. Dyn 2006, 235:1830-1844.
122. Agrawal N., Frederick M.J., Pickering C.R., Bettegowda C., Chang K., Li R.J., et al. Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. Science 2011, 333:1154-1157.
123. Stransky N., Egloff A.M., Tward A.D., Kostic A.D., Cibulskis K., Sivachenko A., et al. The mutational landscape of head and neck squamous cell carcinoma. Science 2011, 333:1157-1160.
124. Agrawal N., Jiao Y., Bettegowda C., Hutfless S.M., Wang Y., David S., et al. Comparative genomic analysis of esophageal adenocarcinoma and squamous cell carcinoma. Cancer Discov 2012, 2:899-905.
125. India Project Team of the International Cancer Genome Consortium Mutational landscape of gingivo-buccal oral squamous cell carcinoma reveals new recurrently-mutated genes and molecular subgroups. Nat. Commun 2013, 4:2873.
126. Song X., Xia R., Li J., Long Z., Ren H., Chen W., et al. Common and complex notch1 mutations in Chinese oral squamous cell carcinoma. Clin. Cancer Res 2014, 20:701-710.
127. Pickering C.R., Zhang J., Yoo S.Y., Bengtsson L., Moorthy S., Neskey D.M., et al. Integrative genomic characterization of oral squamous cell carcinoma identifies frequent somatic drivers. Cancer Discov 2013, 3:770-781.
128. Schneider K.J., Scheer M., Suhr M., Clemens D.L. Ethanol administration impairs pancreatic repair after injury. Pancreas 2012, 41:1272-1279.
129. Morrow D., Cullen J.P., Liu W., Cahill P.A., Redmond E.M. Alcohol inhibits smooth muscle cell proliferation via regulation of the Notch signaling pathway. Arterioscler. Thromb. Vasc. Biol 2010, 30:2597-2603.
130. Hashimoto-Torii K., Kawasawa Y.I., Kuhn A., Rakic P. Combined transcriptome analysis of fetal human and mouse cerebral cortex exposed to alcohol. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:4212-4217.
131. Morrow D., Cullen J.P., Cahill P.A., Redmond E.M. Ethanol stimulates endothelial cell angiogenic activity via a Notch- and angiopoietin-1-dependent pathway. Cardiovasc. Res 2008, 79:313-321.
132. McCarthy N., Eberhart J.K. Gene-ethanol interactions underlying fetal alcohol spectrum disorders. Cell. Mol. Life Sci 2014, 71:2699-2706.
133. Mao H., Diehl A.M., Li Y.X. Sonic hedgehog ligand partners with caveolin-1 for intracellular transport. Lab. Invest 2009, 89:290-300.
134. Zhang C., Ojiaku P., Cole G.J. Forebrain and hindbrain development in zebrafish is sensitive to ethanol exposure involving agrin, Fgf, and sonic hedgehog function. Birth Defects Res. A. Clin Mol. Teratol 2013, 97:8-27.
135. Zhang C., Turton Q.M., Mackinnon S., Sulik K.K., Cole G.J. Agrin function associated with ocular development is a target of ethanol exposure in embryonic zebrafish. Birth Defects Res. A. Clin Mol. Teratol 2011, 91:129-141.
136. Loucks E.J., Ahlgren S.C. Deciphering the role of Shh signaling in axial defects produced by ethanol exposure. Birth Defects Res. A. Clin Mol. Teratol 2009, 85:556-567.
137. Li Y.X., Yang H.T., Zdanowicz M., Sicklick J.K., Qi Y., Camp T.J., et al. Fetal alcohol exposure impairs Hedgehog cholesterol modification and signaling. Lab. Invest 2007, 87:231-240.
138. Chan I.S., Guy C.D., Machado M.V., Wank A., Kadiyala V., Michelotti G., et al. Alcohol activates the hedgehog pathway and induces related procarcinogenic processes in the alcohol-preferring rat model of hepatocarcinogenesis. Alcohol. Clin. Exp. Res 2014, 38:787-800.
139. Jung Y., Brown K.D., Witek R.P., Omenetti A., Yang L., Vandongen M., et al. Accumulation of hedgehog-responsive progenitors parallels alcoholic liver disease severity in mice and humans. Gastroenterology 2008, 134:1532-1543.
140. Yang L., Wang L.S., Chen X.L., Gatalica Z., Qiu S., Liu Z., et al. Hedgehog signaling activation in the development of squamous cell carcinoma and adenocarcinoma of esophagus. Int. J. Biochem. Mol. Biol 2012, 3:46-57.
141. Wei L., Xu Z. Cross-signaling among phosphinositide-3 kinase, mitogen-activated protein kinase and sonic hedgehog pathways exists in esophageal cancer. Int. J. Cancer 2011, 129:275-284.
142. Wang Y., Ding Q., Yen C.J., Xia W., Izzo J.G., Lang J.Y., et al. The crosstalk of mTOR/S6K1 and Hedgehog pathways. Cancer Cell 2012, 21:374-387.
143. Wang Y.F., Chang C.J., Lin C.P., Chang S.Y., Chu P.Y., Tai S.K., et al. Expression of hedgehog signaling molecules as a prognostic indicator of oral squamous cell carcinoma. Head Neck 2012, 34:1556-1561.
144. Cavicchioli Buim M.E., Gurgel C.A., Goncalves Ramos E.A., Lourenco S.V., Soares F.A. Activation of sonic hedgehog signaling in oral squamous cell carcinomas: a preliminary study. Hum. Pathol 2011, 42:1484-1490.
145. Anastas J.N., Moon R.T. WNT signalling pathways as therapeutic targets in cancer. Nat. Rev. Cancer 2013, 13:11-26.
146. Lecarpentier Y., Claes V., Duthoit G., Hebert J.L. Circadian rhythms, Wnt/beta-catenin pathway and PPAR alpha/gamma profiles in diseases with primary or secondary cardiac dysfunction. Front. Physiol 2014, 5:429.
147. Vangipuram S.D., Lyman W.D. Ethanol affects differentiation-related pathways and suppresses Wnt signaling protein expression in human neural stem cells. Alcohol. Clin. Exp. Res 2012, 36:788-797.
148. Mercer K.E., Hennings L., Sharma N., Lai K., Cleves M.A., Wynne R.A., et al. Alcohol consumption promotes diethylnitrosamine-induced hepatocarcinogenesis in male mice through activation of the Wnt/beta-catenin signaling pathway. Cancer Prev. Res. (Phila.) 2014, 7:675-685.
149. Santoro A., Pannone G., Papagerakis S., McGuff H.S., Cafarelli B., Lepore S., et al. Beta-catenin and epithelial tumors: a study based on 374 oropharyngeal cancers. Biomed Res. Int 2014, 2014:948264.
150. Osei-Sarfo K., Tang X.H., Urvalek A.M., Scognamiglio T., Gudas L.J. The molecular features of tongue epithelium treated with the carcinogen 4-nitroquinoline-1-oxide and alcohol as a model for HNSCC. Carcinogenesis 2013, 34:2673-2681.
151. White R.A., Malkoski S.P., Wang X.J. TGFbeta signaling in head and neck squamous cell carcinoma. Oncogene 2010, 29:5437-5446.
152. Principe D.R., Doll J.A., Bauer J., Jung B., Munshi H.G., Bartholin L., et al. TGF-beta: duality of function between tumor prevention and carcinogenesis. J. Natl Cancer Inst 2014, 106:djt369.
153. Pickup M., Novitskiy S., Moses H.L. The roles of TGFbeta in the tumour microenvironment. Nat. Rev. Cancer 2013, 13:788-799.
154. Miller M.W. Expression of transforming growth factor-beta in developing rat cerebral cortex: effects of prenatal exposure to ethanol. J. Comp. Neurol 2003, 460:410-424.
155. Gerjevic L.N., Liu N., Lu S., Harrison-Findik D.D. Alcohol activates TGF-beta but inhibits BMP receptor-mediated smad signaling and Smad4 binding to hepcidin promoter in the liver. Int. J. Hepatol 2012, 2012:459278..
156. Brown S.D., Brown L.A. Ethanol (EtOH)-induced TGF-beta1 and reactive oxygen species production are necessary for EtOH-induced alveolar macrophage dysfunction and induction of alternative activation. Alcohol. Clin. Exp. Res 2012, 36:1952-1962.
157. Law B.A., Carver W.E. Activation of cardiac fibroblasts by ethanol is blocked by TGF-beta inhibition. Alcohol. Clin. Exp. Res 2013, 37:1286-1294.
158. Tahir M., Rehman M.U., Lateef A., Khan R., Khan A.Q., Qamar W., et al. Diosmin protects against ethanol-induced hepatic injury via alleviation of inflammation and regulation of TNF-alpha and NF-kappaB activation. Alcohol 2013, 47:131-139.
159. Iimuro Y., Gallucci R.M., Luster M.I., Kono H., Thurman R.G. Antibodies to tumor necrosis factor alfa attenuate hepatic necrosis and inflammation caused by chronic exposure to ethanol in the rat. Hepatology 1997, 26:1530-1537.
160. Ye Q., Wang X., Wang Q., Xia M., Zhu Y., Lian F., et al. Cytochrome P4502E1 inhibitor, chlormethiazole, decreases lipopolysaccharide-induced inflammation in rat Kupffer cells with ethanol treatment. Hepatol. Res 2013, 43:1115-1123.
161. Lin C.W., Hsieh Y.S., Hsin C.H., Su C.W., Lin C.H., Wei L.H., et al. Effects of NFKB1 and NFKBIA gene polymorphisms on susceptibility to environmental factors and the clinicopathologic development of oral cancer. PLoS ONE 2012, 7:e35078.
162. Aroor A.R., Shukla S.D. MAP kinase signaling in diverse effects of ethanol. Life Sci 2004, 74:2339-2364.
163. Broek R.V., Mohan S., Eytan D.F., Chen Z., Van Waes C. The PI3K/Akt/mTOR axis in head and neck cancer: functions, aberrations, crosstalk, and therapies. Oral Dis 2013, accessed 13.11.12; Epub ahead of print.
164. Zeng T., Zhang C.L., Song F.Y., Zhao X.L., Yu L.H., Zhu Z.P., et al. PI3K/Akt pathway activation was involved in acute ethanol-induced fatty liver in mice. Toxicology 2012, 296:56-66.
165. Neasta J., Ben Hamida S., Yowell Q.V., Carnicella S., Ron D. AKT signaling pathway in the nucleus accumbens mediates excessive alcohol drinking behaviors. Biol. Psychiatry 2011, 70:575-582.
166. Liu L., Cao J.X., Sun B., Li H.L., Xia Y., Wu Z., et al. Mesenchymal stem cells inhibition of chronic ethanol-induced oxidative damage via upregulation of phosphatidylinositol-3-kinase/Akt and modulation of extracellular signal-regulated kinase 1/2 activation in PC12 cells and neurons. Neuroscience 2010, 167:1115-1124.
167. Umoh N.A., Walker R.K., Al-Rubaiee M., Jeffress M.A., Haddad G.E. Acute alcohol modulates cardiac function as PI3K/Akt regulates oxidative stress. Alcohol. Clin. Exp. Res 2014, 38:1847-1864.
168. Thomas S.M., Bhola N.E., Zhang Q., Contrucci S.C., Wentzel A.L., Freilino M.L., et al. Cross-talk between G protein-coupled receptor and epidermal growth factor receptor signaling pathways contributes to growth and invasion of head and neck squamous cell carcinoma. Cancer Res 2006, 66:11831-11839.
169. Agudelo M., Yndart A., Morrison M., Figueroa G., Munoz K., Samikkannu T., et al. Differential expression and functional role of cannabinoid genes in alcohol users. Drug Alcohol Depend 2013, 133:789-793.
170. Kelm M.K., Criswell H.E., Breese G.R. Ethanol-enhanced GABA release: a focus on G protein-coupled receptors. Brain Res. Rev 2011, 65:113-123.
171. Homann N., Karkkainen P., Koivisto T., Nosova T., Jokelainen K., Salaspuro M. Effects of acetaldehyde on cell regeneration and differentiation of the upper gastrointestinal tract mucosa. J. Natl Cancer Inst 1997, 89:1692-1697.
172. Mascres C., Ming-Wen F., Joly J.G. Morphologic changes of the esophageal mucosa in the rat after chronic alcohol ingestion. Exp. Pathol 1984, 25:147-153.
173. Wimberly A.L., Forsyth C.B., Khan M.W., Pemberton A., Khazaie K., Keshavarzian A. Ethanol-induced mast cell-mediated inflammation leads to increased susceptibility of intestinal tumorigenesis in the APC Delta468 min mouse model of colon cancer. Alcohol. Clin. Exp. Res 2013, 37(Suppl. 1):E199-E208.
174. Yu K., Yang J., Wang F., Chen L., Lu Y., Luo J., et al. Ethanol supports macrophage recruitment and reinforces invasion and migration of lewis lung carcinoma. Alcohol. Clin. Exp. Res 2014, 38:2597-2606.
175. Polakis P. Wnt signaling in cancer. Cold Spring Harb. Perspect. Biol 2012, 4.
176. Kwon C., Cheng P., King I.N., Andersen P., Shenje L., Nigam V., et al. Notch post-translationally regulates beta-catenin protein in stem and progenitor cells. Nat. Cell Biol 2011, 13:1244-1251.
177. Wakabayashi N., Shin S., Slocum S.L., Agoston E.S., Wakabayashi J., Kwak M.K., et al. Regulation of notch1 signaling by nrf2: implications for tissue regeneration. Sci. Signal 2010, 3:ra52.
178. Soffritti M., Belpoggi F., Cevolani D., Guarino M., Padovani M., Maltoni C. Results of long-term experimental studies on the carcinogenicity of methyl alcohol and ethyl alcohol in rats. Ann. N. Y. Acad. Sci 2002, 982:46-69.
179. Nachiappan V., Mufti S.I., Eskelson C.D. Ethanol-mediated promotion of oral carcinogenesis in hamsters: association with lipid peroxidation. Nutr. Cancer 1993, 20:293-302.
180. Tsutsumi M., George J., Ishizawa K., Fukumura A., Takase S. Effect of chronic dietary ethanol in the promotion of N-nitrosomethylbenzylamine-induced esophageal carcinogenesis in rats. J. Gastroenterol. Hepatol 2006, 21:805-813.
181. Aze Y., Toyoda K., Furukawa F., Mitsumori K., Takahashi M. Enhancing effect of ethanol on esophageal tumor development in rats by initiation of diethylnitrosamine. Carcinogenesis 1993, 14:37-40.
182. Elzay R.P. Effect of alcohol and cigarette smoke as promoting agents in hamster pouch carcinogenesis. J. Dent. Res 1969, 48:1200-1205.
183. Elzay R.P. Local effect of alcohol in combination with DMBA on hamster cheek pouch. J. Dent. Res 1966, 45:1788-1795.
184. Mufti S.I., Becker G., Sipes I.G. Effect of chronic dietary ethanol consumption on the initiation and promotion of chemically-induced esophageal carcinogenesis in experimental rats. Carcinogenesis 1989, 10:303-309.
185. Shikata N., Singh Y., Senzaki H., Shirai K., Watanabe T., Tsubura A. Effect of ethanol on esophageal cell proliferation and the development of N-methyl-N'-nitro-N-nitrosoguanidine induced-esophageal carcinoma in shrews. J. Cancer Res. Clin. Oncol 1996, 122:613-618.
186. Kaneko M., Morimura K., Nishikawa T., Wanibuchi H., Osugi H., Kinoshita H., et al. Weak enhancing effects of simultaneous ethanol administration on chemically induced rat esophageal tumorigenesis. Oncol. Rep 2002, 9:1069-1073.
187. Morimura K., Hori T., Kaneko M., Nishikawa T., Nishikawa A., Wanibuchi H., et al. Promotion of chemically induced rat esophageal tumorigenesis with post-initiation ethanol modification. Teratog. Carcinog. Mutagen 2001, 21:295-301.
188. Gurski R.R., Schirmer C.C., Kruel C.R., Komlos F., Kruel C.D., Edelweiss M.I. Induction of esophageal carcinogenesis by diethylnitrosamine and assessment of the promoting effect of ethanol and N-nitrosonornicotine: experimental model in mice. Dis. Esophagus 1999, 12:99-105.
189. D'Souza El-Guindy N.B., Kovacs E.J., De Witte P., Spies C., Littleton J.M., de Villiers W.J., et al. Laboratory models available to study alcohol-induced organ damage and immune variations: choosing the appropriate model. Alcohol. Clin. Exp. Res 2010, 34:1489-1511.
190. Roberts A.J., Heyser C.J., Koob G.F. Operant self-administration of sweetened versus unsweetened ethanol: effects on blood alcohol levels. Alcohol. Clin. Exp. Res 1999, 23:1151-1157.
191. Overstreet D.H., Kampov-Polevoy A.B., Rezvani A.H., Murrelle L., Halikas J.A., Janowsky D.S. Saccharin intake predicts ethanol intake in genetically heterogeneous rats as well as different rat strains. Alcohol. Clin. Exp. Res 1993, 17:366-369.
192. Yoneyama N., Crabbe J.C., Ford M.M., Murillo A., Finn D.A. Voluntary ethanol consumption in 22 inbred mouse strains. Alcohol 2008, 42:149-160.
193. Belknap J.K., Crabbe J.C., Young E.R. Voluntary consumption of ethanol in 15 inbred mouse strains. Psychopharmacology (Berl) 1993, 112:503-510.
194. Kampov-Polevoy A.B., Garbutt J.C., Janowsky D.S. Association between preference for sweets and excessive alcohol intake: a review of animal and human studies. Alcohol Alcohol 1999, 34:386-395.
195. Hubbell C.L., Marglin S.H., Spitalnic S.J., Abelson M.L., Wild K.D., Reid L.D. Opioidergic, serotonergic, and dopaminergic manipulations and rats' intake of a sweetened alcoholic beverage. Alcohol 1991, 8:355-367.
196. Gilpin N.W., Misra K., Koob G.F. Neuropeptide Y in the central nucleus of the amygdala suppresses dependence-induced increases in alcohol drinking. Pharmacol. Biochem. Behav 2008, 90:475-480.
197. Tabakoff B., Hoffman P.L. Animal models in alcohol research. Alcohol. Res. Health 2000, 24:77-84.
198. Feith D.J., Pegg A.E., Fong L.Y. Targeted expression of ornithine decarboxylase antizyme prevents upper aerodigestive tract carcinogenesis in p53-deficient mice. Carcinogenesis 2013, 34:570-576.
199. Tan M., Myers J.N., Agrawal N. Oral cavity and oropharyngeal squamous cell carcinoma genomics. Otolaryngol. Clin. North Am 2013, 46:545-566.
200. Jeck W.R., Parker J., Carson C.C., Shields J.M., Sambade M.J., Peters E.C., et al. Targeted next generation sequencing identifies clinically actionable mutations in patients with melanoma. Pigment Cell Melanoma Res 2014, 27:653-663.
201. Song Y., Li L., Ou Y., Gao Z., Li E., Li X., et al. Identification of genomic alterations in oesophageal squamous cell cancer. Nature 2014, 509:91-95.
202. Manna S.K., Thompson M.D., Gonzalez F.J. Application of mass spectrometry-based metabolomics in identification of early noninvasive biomarkers of alcohol-induced liver disease using mouse model. Adv. Exp. Med. Biol 2015, 815:217-238.
203. Shi X., Yao D., Chen C. Identification of N-acetyltaurine as a novel metabolite of ethanol through metabolomics-guided biochemical analysis. J. Biol. Chem 2012, 287:6336-6349.
204. Jabbour Z., do Nascimento C., Kotake B.G., El-Hakim M., Henderson J.E., de Albuquerque Junior R.F. Assessing the oral microbiota of healthy and alcohol-treated rats using whole-genome DNA probes from human bacteria. Arch. Oral Biol 2013, 58:317-323.
205. Yu G., Gail M.H., Shi J., Klepac-Ceraj V., Paster B.J., Dye B.A., et al. Association between upper digestive tract microbiota and cancer-predisposing states in the esophagus and stomach. Cancer Epidemiol. Biomarkers Prev 2014, 23:735-741.